Ahammune Biosciences

Ahammune Biosciences Pvt. Ltd. is a biotech company focused on developing treatments for chronic skin diseases by targeting the causal mechanisms that lead to cellular dysfunction. The company aims to provide permanent relief with minimal or no side effects through its innovative molecules. Ahammune's interdisciplinary team of scientists is dedicated to translating scientific breakthroughs into effective dermatological treatments. The company primarily serves patients with unmet needs in the dermatology market, particularly those suffering from conditions like vitiligo. Ahammune's business model involves research and development of therapeutic molecules, which are then monetized through partnerships, licensing, or direct sales. The company has raised funds in a Pre Series A round to support its mission of enriching lives by removing the fear and stigma associated with skin diseases. Keywords: dermatology, biotech, chronic diseases, immune triggers, vitiligo, cellular pathways, therapeutic molecules, interdisciplinary team, Pre Series A, skin treatment.